ABUS

#2131
Arbutus Biopharma Corporation - Common Stock
4.5 6 USD
-0.87%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
4.53
4.58
Jahresspanne
3.04
5.10
Tagesänderung
-0.87%
Monatliche Änderung
+10.41%
6 month change
+5.07%
Jahresänderung
+33.33%
Vorheriger Schlusskurs
4.6 0
Open
4.5 7
Tief
4.5 3
High
4.5 8
Volumen
635
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert 202020212022202320242025 TTM

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Nachrichten